Glaucoma is a silent illness; most people have no early symptoms and do not notice as their peripheral vision diminishes or blind spots occur. The disease affects more than 2.3 million Americans age 40 and older. Another 2 million do not know they have…
Minimally Invasive Procedure With Phaco Reduces IOP, Medication Use In Glaucoma Patients
A minimally invasive glaucoma treatment combined with cataract extraction lowered IOP and reduced glaucoma medications, with fewer complications than trabeculectomy, according to study results.
Statement By The American Academy Of Ophthalmology Regarding Children’s Vision And Eye Health And 3-D Digital Products
Recently Nintendo issued a warning about their new 3-D handheld game device that urged parents to prevent children under age 6 years from prolonged viewing of the device’s digital images, in order to avoid possible damage to visual development. Other 3…
Through The Eyes of a Child: Understanding Retinopathy through ROP (The Friedenwald Lecture)
NeoVista Epi-Retinal Strontium 90 Treatment for AMD: Update 4
NeoVista just released an update, discussing the first commercial utilization of its Epimacular Brachytherapy device in Germany. The Epi-Rad device, now renamed as the VIDION ANV (Anti Neo Vascular Therapy System) has been commercialized in Europe since November 2009. The…
Research and Markets: Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/fb0df2/ophthalmic_devices) has announced the addition of GlobalData’s new report “Ophthalmic Devices Market Outlook in India to 2016 – Vision Care, Cataract and Refractive Surgery Devices and Others” to their offering. Ophthalmic Devices Market Outlook in India…